ADVERTISEMENT
Second Person Dies in Latest Ebola Outbreak in DRC
Second Person Dies in Latest Ebola Outbreak in DRC
The woman may have had a link to another person, who was married to an Ebola survivor and who died a few days previously in Democratic Republic of Congo.
Second Person Dies in Latest Ebola Outbreak in DRC
Second Person Dies in Latest Ebola Outbreak in DRC

The woman may have had a link to another person, who was married to an Ebola survivor and who died a few days previously in Democratic Republic of Congo.

The woman may have had a link to another person, who was married to an Ebola survivor and who died a few days previously in Democratic Republic of Congo.

disease & medicine

Pfizer, SARS-CoV-2, COVID-19, pandemic, coronavirus, vaccine, vaccination, Israel, B.1.1.7, B.1.351, variant, disease
Pfizer’s COVID-19 Vaccine Reduces Viral Load: Study
Asher Jones | Feb 10, 2021 | 2 min read
Preliminary results from an Israel-based study suggest that one dose of the vaccine reduces infectiousness—a key factor in slowing virus spread.
Emil Freireich, cancer, leukemia, platelets, blood, chemotherapy, University of Texas MD Anderson Cancer Center
Pioneering Cancer Researcher Emil Freireich Dies at 93
Asher Jones | Feb 5, 2021 | 3 min read
The oncologist developed lifesaving childhood leukemia treatments and revolutionized chemotherapy.
New Bacterium Linked to Chimp Deaths
Asher Jones | Feb 3, 2021 | 2 min read
The newly discovered microbe seems to be responsible for a mysterious neurological disease that has killed dozens of critically endangered Western chimpanzees.
Respected Medical Geneticist Sir Peter Harper Dies at 81
Catherine Offord | Feb 2, 2021 | 4 min read
The Cardiff University researcher was famous both for his work on genetic disorders and for his documentation of the history of his field.
Obituary, obituaries, Rutgers university, COVID-19, SARS-CoV-2, coronavirus, pandemic, saliva, diagnostics, disease & medicine, saliva testing, techniques
Andrew Brooks, Designer of COVID-19 Saliva Test, Dies at 51
Amanda Heidt | Feb 2, 2021 | 3 min read
The Rutgers University researcher created the first FDA-authorized spit test, which has since been used by millions of people.
Reduced Adult Neurogenesis Linked with Alzheimer’s Disease
Abby Olena, PhD | Feb 1, 2021 | 6 min read
Manipulating the production of new neurons can improve cognition in animal models of the disease, raising the possibility that figuring out a way for humans to make more neurons could make a difference for people with dementia.
Are Phages Overlooked Mediators of Health and Disease?
Catherine Offord | Feb 1, 2021 | 10+ min read
Bacteria-infecting viruses affect the composition and behavior of microbes in the mammalian gut—and perhaps influence human biology.
Infographic: Trans-kingdom Interactions in the Gut
Catherine Offord | Feb 1, 2021 | 1 min read
Phages interact with bacteria and eukaryotic cells in ways that researchers suspect influence mammalian health.
SARS-CoV-2, COVID-19, coronavirus, pandemic, virus, vaccine, vaccination, outbreak, infectious disease, Johnson & Johnson, Moderna, Pfizer, drug development
One-Shot COVID-19 Vaccine Prevents Severe Disease
Asher Jones | Jan 29, 2021 | 2 min read
Johnson & Johnson’s vaccine is less effective at preventing COVID-19 than other approved vaccines are, but experts say it could still be an important tool in curbing the pandemic.
Antibody Spike Months After Ebola Infection Surprisingly Common
Catherine Offord | Jan 27, 2021 | 4 min read
A study of people in Sierra Leone suggests that the virus can lie in hiding from the immune system before re-emerging later and sparking a new response—although researchers didn’t examine whether this could make people infectious again.
COVID-19, SARS-CoV-2, pandemic, B.1.1.7, 501Y.V2, B.1.351, vaccine, immunity, virus, coronavirus, Moderna, South Africa, variant
Moderna Developing Booster Shot for New Virus Variant B.1.351
Asher Jones | Jan 25, 2021 | 2 min read
New data suggest that the company’s approved COVID-19 vaccine protects against different virus variants, but could be less effective against the one that originated in South Africa.
New SARS-CoV-2 Variant Could Evade Antibodies
Lisa Winter | Jan 22, 2021 | 3 min read
A preprint casts doubt on vaccine effectiveness in light of certain mutations in the 501Y.V2 variant that emerged from South Africa.
Q&A: Natural History Museums’ Role in Pandemic Surveillance
Max Kozlov | Jan 21, 2021 | 5 min read
Host vouchering, the practice of preserving species known to harbor infectious diseases, can be used to help determine a pathogen’s source, scientists say.
COVID-19, SARS-CoV-2, coronavirus, pandemic, variant, L452R, B.1.1.7, virus,
Coronavirus Variant Linked to COVID-19 Outbreaks in California
Asher Jones | Jan 19, 2021 | 2 min read
It’s too early to know whether the L452R version of SARS-CoV-2 is highly infectious like the B.1.1.7 UK variant that is also spreading around the US.
The Promise of Scientific Partnerships with People on the Spectrum
Laura Dattaro, Spectrum | Jan 18, 2021 | 10+ min read
Five collaborations involving autistic scientists and experts are advancing autism research, from lending support for theories of the condition to shoring up trials of new treatments.
Past SARS-CoV-2 Infection Mostly Protects Survivors
Max Kozlov | Jan 14, 2021 | 2 min read
A large study of UK healthcare workers finds that immunity after coronavirus infection lasts for months, but those with antibodies may still be able to carry and spread the virus upon reexposure.
High Risk of Bias in Early COVID-19 Studies: Meta-Analysis
Max Kozlov | Jan 14, 2021 | 5 min read
Few peer-reviewed clinical papers on the pandemic contained original data, and many of those that did had poor experimental design.
cancer lung ACS death mortality
Record Drop in US Cancer Death Rate
Asher Jones | Jan 13, 2021 | 2 min read
From 2017 to 2018, cancer deaths dropped by 2.4 percent, the largest single-year improvement recorded in 70 years of American Cancer Society annual cancer reports.
brown fat, metabolism, cardiovascular disease, cardiometabolic disease, genetics & genomics, immunology, Q&A, adipose tissue, obesity
Q&A: Brown Fat Linked to Better Cardio and Metabolic Health
Amanda Heidt | Jan 12, 2021 | 5 min read
Paul Cohen of the Rockefeller University describes his study of thousands of people, finding that the energy-burning tissue is tied to a lower risk of for several diseases, including type 2 diabetes, high blood pressure, and heart disease.
ADVERTISEMENT